ARCHIVES

Report Tells NCI to Increase Funding for SPOREs.

This article is from The Cancer Letter archive.

Vol. 32 No. 25 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says

February 19, 1993

Clinton to Propose Increase for NIH & NCI Significantly Higher Than In Previous Years

January 9, 1998

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

NCI Cooperative Group Clinical Trials Approved

October 29, 2010